Pharmacy Report Archives - Page 3 of 151 - Becker's Hospital Review

Lilly sues over retatrutide sales | Inside a system's fast specialty pharmacy launch | FDA rejects rival to Novartis cancer therapy | Hims & Hers to sell compounded peptides | Why AstraZeneca's $400B Bristol Myers deal collapsed

Plus: 3 big questions surrounding Trump’s childhood vaccine order August 12, 2026 1. How one system launched a specialty pharmacy in 6 months Full story 2. Lilly sues 6 companies over alleged retatrutide sales Full story 3. How are hospitals…

The court fights putting 340B in limbo | 8 top hospital pharmacies | 8 GLP-1 updates | FDA extends drug-tracking exemptions | Prescription spending shifts: 5 notes

Plus: Trump orders childhood vaccine overhaul August 11, 2026 1. What separates 8 hospital pharmacies from the rest of the country Full story 2. Court battles leaving the 340B program in legal limbo Full story 3. Cottage Health + Sinai…

340B legislation advances in DC | NY hospital has 1st 'age-friendly' pharmacy | Court backs Lilly, Novo in GLP-1 antitrust fight | FDA OKs melanoma therapy, 1st narcolepsy type 1 drug

Plus: Michigan Medicine taps new pharmacy leader August 10, 2026 1. Congress advances new wave of 340B legislation: What to know Full story 2. New York hospital earns nation’s 1st age-friendly pharmacy designation Full story 3. Traditional training moves teams…

Meet the CPOs of US News' Best Hospitals | 340B cuts threaten hospital margins | CMS to share GLP-1 Bridge data | Lilly widens lead over Novo | 10 systems seeking pharmacy leaders

Plus: FDA OKs Modern’s mRNA flu shot August 6, 2026 1. Meet the CPOs of US News’ Best Hospitals Full story 2. CMS to begin sharing GLP-1 Bridge utilization data with Part D plans Full story 3. Traditional training moves teams…

Patients' biggest pharmacy priorities | Hospitals cite patient harm from drug shortages | GLP-1s and pregnancy: What to know | Nation's 2nd public extended PharmD program to launch | CVS revamps GLP-1 program

Plus: 1 in 6 prescribed medications restarted after discharge August 5, 2026 1. What patients want now: 17 pharmacy leaders weigh in Full story 2. Hospitals cite patient harm from injectable drug shortages: 6 notes Full story 3. 3 health…

Lilly expands access to blockbuster obesity drug | GLP-1 coverage cuts reshape pharmacy | 4 health plans rethink specialty pharmacy | Oil prices threaten drug costs | Cleveland Clinic launches drone Rx delivery

Plus: Pharmacy school placed on accreditation probation August 4, 2026 1. Eli Lilly lets physicians request access to its most powerful obesity drug Full story 2. How 4 health plans are innovating with specialty pharmacy Full story 3. Traditional training moves…

340B rebate fight reignites | 9 new drug shortages | Pharma megamerger in the works? | Eli Lilly insulin pricing probe revived | Polypharmacy raises mortality 38%: 4 notes

Plus: Possible GLP-1 treatment for alcohol use disorder August 3, 2026 1. HRSA revises 340B rebate pilot program, hospital groups push back Full story 2. 9 new drugs in shortage Full story 3. 3 health systems share how they centralized…

Drug tariff begins tomorrow | Who wins under CMS' 340B proposal? | Memorial Hermann's 'aggressive' bet on retail pharmacy | 10 systems hiring pharmacy leaders | A new reporting push for compounded drugs

Plus: FDA panel reject Duchenne therapy over efficacy concerns July 30, 2026 1. Trump’s drug tariff takes effect tomorrow: What to know Full story 2. 5 pharmacies and counting: Why Memorial Hermann chose ‘aggressive’ retail expansion Full story 3. Traditional training moves…

Medicare Part D shakeup ahead | 4 pharmacy policy changes to watch | CVS looks to dismiss 340B lawsuits | FDA releases 17 peptide drug guidances | Pa. pharmacies face estradiol patch shortage

Plus: 24 health systems adding new C-suite roles July 29, 2026 1. CMS to end Medicare Part D stabilization program Full story 2. 4 pharmacy policy changes to watch Full story 3. Pharmacy is transforming from a cost center to a…

Betting sites take on FDA drug approvals | Judge rejects ND's bid to keep 340B law | Nationwide thyroid drug recall | FDA OKs new ADHD drug | Medicare pharmacy access falls short

Plus: ECRI, ISMP warn against FDA panel’s peptide compounding vote July 28, 2026 1. Betting sites take on FDA drug approvals, trial results Full story 2. Judge rejects North Dakota bid to pause 340B ruling Full story 3. How are…